Following Coronary Intravascular Lithotripsy, Advanced Treatments Introduced in Succession

"Personalized Treatment Realized Through Diversified Strategies for Severe Calcified Lesions"

Samsung Medical Center announced on April 8 that it has successfully performed Korea's first orbital atherectomy. The procedure was carried out on a patient with a moderately calcified lesion in the coronary artery.

Professors Youngbin Song (right) and Kihong Choi from the Department of Cardiology at Samsung Medical Center successfully performed Korea's first orbital atherectomy on the 8th. Samsung Medical Center

Professors Youngbin Song (right) and Kihong Choi from the Department of Cardiology at Samsung Medical Center successfully performed Korea's first orbital atherectomy on the 8th. Samsung Medical Center

View original image

Coronary artery calcification is commonly seen in elderly patients, as well as those with diabetes or impaired kidney function. These calcified vessels become rigid, making stent expansion difficult and increasing the risk of procedural failure and complications.


Orbital Atherectomy System (OAS) is a treatment in which a diamond-coated device (crown) rotates in an elliptical motion, selectively removing calcified lesions while minimizing vascular injury. It helps soften the blood vessels, making it safer and more consistent to expand narrowed coronary arteries during procedures.


Unlike conventional atherectomy procedures, OAS can be used on a wide range of vessel diameters, from 2.5 mm to 4.0 mm, simply by adjusting the rotational speed without the need to change devices. This is considered a significant advantage.


The interventional cardiology team at Samsung Medical Center's Heart and Vascular Hospital plans to use this first case as an opportunity to establish OAS procedural protocols tailored for Korean patients. They also intend to combine this technique with advanced intravascular imaging technologies (such as OCT or IVUS) to develop optimized treatment approaches.


Professor Youngbin Song, who performed the first procedure in Korea, stated, "Moderately calcified lesions are a significant factor because they increase procedural difficulty and greatly influence patient outcomes. With the introduction of OAS, more precise and predictable interventions are now possible, which will be a major help in developing personalized treatment strategies for patients."



Samsung Medical Center also became the first in Korea to perform coronary intravascular lithotripsy, an advanced procedure for removing coronary artery calcified lesions, in April of last year.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing